Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectum Cancer, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Testing effectiveness (Phase 2)Ended earlyNCT00033306
What this trial is testing

BMS-247550 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 2
Testing effectiveness (Phase 2)Ended earlyNCT00004193
What this trial is testing

ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 25
Large-scale testing (Phase 3)Study completedNCT00238381
What this trial is testing

Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 336
Early research (Phase 1)Study completedNCT00138177
What this trial is testing

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage III Colon Cancer+4 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Testing effectiveness (Phase 2)Study completedNCT00290615
What this trial is testing

Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Herbert Hurwitz 30
Testing effectiveness (Phase 2)Study completedNCT00004860
What this trial is testing

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Not applicableUnknownNCT04715308
What this trial is testing

Patient Experiences Following Urinary Diversion as Part of Surgery for Advanced and Recurrent Rectal Cancer

Who this might be right for
Patient SatisfactionQuality of LifePatient Participation
St Vincent's University Hospital, Ireland 1,200
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Not applicableStudy completedNCT01590147
What this trial is testing

Supportive Intervention Programs Study

Who this might be right for
FatigueNausea and VomitingPain+4 more
Wake Forest University 15
Large-scale testing (Phase 3)UnknownNCT00002893
What this trial is testing

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 900
Testing effectiveness (Phase 2)WithdrawnNCT01270438
What this trial is testing

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT01116687
What this trial is testing

RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00268333
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 39
Testing effectiveness (Phase 2)Study completedNCT00004187
What this trial is testing

Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00039273
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 44
Next Page